We also verified that miR-137 is a diagnostic tumor-suppressive microRNA (miRNA) that targets SPHK2 to promote M1-type TAM polarization, which successfully established glioma cell lines with SPHK2 knockdown using the lentiviral infection method (11). Here, SPHK2 is linked to central nervous system cancer.